Status:
RECRUITING
STAR-LIFE: a Post-market Registry on MINIject
Lead Sponsor:
iSTAR Medical
Conditions:
Open Angle Glaucoma
Eligibility:
All Genders
18+ years
Brief Summary
As part of the post-market clinical follow-up (PMCF), this registry is developed to ensure real-world data collection on MINIject device.
Detailed Description
The goal of the registry is to collect data of the MINIject in a real-life setting. The registry has 3 main objectives: the collection of real-world evidence on the usability of the device, the patien...
Eligibility Criteria
Inclusion
- 18+ years
- diagnosed with open angle glaucoma, who has been or will be implanted with CE-marked MINIject
- able to give consent
Exclusion
- eyes with angle closure glaucoma
- eyes with traumatic, malignant, uveitic or neovascular glaucoma or discernible congenital anomalies of the anterior chamber angle
- patients with known intolerance or hypersensitivity to silicone
- patients unable to give consent
Key Trial Info
Start Date :
July 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT05269680
Start Date
July 20 2022
End Date
July 1 2026
Last Update
February 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitatsklinik fur Augenheilkunde Inselspital
Bern, Switzerland, 3010